Contact
searchSearch
HMP Global

Office-Based Labs (OBL) Corner

Features

Original Research
Endovascular Treatment of Peripheral Arterial Disease and Critical Limb-Threatening Ischemia Can Be Safely Performed With 4F Arterial Access
03/19/2025
Sreejit Nair, MD; Joseph Puma, DO; Justin A. Ratcliffe, MD; Ashwani Sastry, MD
This study evaluates the safety and feasibility of utilizing a 4F arterial access approach for treating PAD and CLTI in an outpatient setting.
This study evaluates the safety and feasibility of utilizing a 4F arterial access approach for treating PAD and CLTI in an outpatient setting.
This study evaluates the safety...
03/19/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Interview
Update on CLI Patients and Complications From the OEIS National Registry
12/01/2024
Bret N. Wiechmann, MD, FSIR, FAHA
At AMP 2024, interventional radiologist Bret Wiechmann, MD, discussed his presentation on the OEIS Registry, which details outcomes within outpatient interventional suites to promote quality and identify benchmarks for best practices.
At AMP 2024, interventional radiologist Bret Wiechmann, MD, discussed his presentation on the OEIS Registry, which details outcomes within outpatient interventional suites to promote quality and identify benchmarks for best practices.
At AMP 2024, interventional...
12/01/2024
Vascular Disease Management
OBL Corner
OBL Spotlight: Advanced Heart & Vascular Institute of Hunterdon
10/31/2024
Vascular Disease Management recently spoke with interventional cardiologist Andrey Espinoza, MD, about this office-based lab (OBL) in Flemington, New Jersey.
Vascular Disease Management recently spoke with interventional cardiologist Andrey Espinoza, MD, about this office-based lab (OBL) in Flemington, New Jersey.
Vascular Disease Management...
10/31/2024
Vascular Disease Management
Dr Bret Wiechmann
AMP 2024
OEIS National Registry: An Update on CLI Patients and Complications
09/18/2024
Bret N. Wiechmann, MD, FSIR, FAHA
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann...
09/18/2024
Vascular Disease Management
Dr Laiq Raja
AMP 2024
How to Manage Complex CLI Patients With Wounds in an Outpatient Program
08/14/2024
M. Laiq Raja, MD, FACC, FSCAI
Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex CLI)patients with wounds in an outpatient program.
Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex CLI)patients with wounds in an outpatient program.
Laiq Raja, MD, FACC, FSCAI, from...
08/14/2024
Vascular Disease Management
Interview
Starting an OBL From Scratch
03/13/2024
Michelle Maneevese, MD
As part of an Early Career Session at ISET 2024, Michelle Maneevese, MD, presented “Starting an OBL from Scratch,” an overview of how she opened her office-based lab (OBL), and gave advice for those thinking of starting their own OBL.
As part of an Early Career Session at ISET 2024, Michelle Maneevese, MD, presented “Starting an OBL from Scratch,” an overview of how she opened her office-based lab (OBL), and gave advice for those thinking of starting their own OBL.
As part of an Early Career...
03/13/2024
Vascular Disease Management
Commentary
What Not To Do in an Office-Based Lab
03/08/2024
Moiz Shah, MD; John Blebea, MD, MBA
Careful selection of which cases not to take is an effective way of avoiding complications in an OBL. Determining what cases to avoid is largely dependent on 4 major variables: the physician, the patient, the procedure, and the OBL itself.
Careful selection of which cases not to take is an effective way of avoiding complications in an OBL. Determining what cases to avoid is largely dependent on 4 major variables: the physician, the patient, the procedure, and the OBL itself.
Careful selection of which cases...
03/08/2024
Vascular Disease Management
Dr. Raja
AMP 2023
Benefits of Running an Office-Based Lab
11/15/2023
M. Laiq Raja, MD, FACC, FSCAI
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional...
11/15/2023
Vascular Disease Management
Chris LeSar, MD
AMP 2023
Inspiration to Open an Office-Based Lab
11/15/2023
Chris LeSar, MD, FACS, RVT
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the...
11/15/2023
Vascular Disease Management
Drs. Wiechmann, Davis, and Secemsky
Vascular Voices Podcast
Using Atherectomy to Treat CLI and Why OBLs Are Needed
10/18/2023
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret...
10/18/2023
Vascular Disease Management

Videos & Podcasts

Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr Bret Wiechmann
AMP 2024
OEIS National Registry: An Update on CLI Patients and Complications
09/18/2024
Bret N. Wiechmann, MD, FSIR, FAHA
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann...
09/18/2024
Vascular Disease Management
Dr. Raja
AMP 2023
Benefits of Running an Office-Based Lab
11/15/2023
M. Laiq Raja, MD, FACC, FSCAI
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional...
11/15/2023
Vascular Disease Management
Chris LeSar, MD
AMP 2023
Inspiration to Open an Office-Based Lab
11/15/2023
Chris LeSar, MD, FACS, RVT
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the...
11/15/2023
Vascular Disease Management
Drs. Wiechmann, Davis, and Secemsky
Vascular Voices Podcast
Using Atherectomy to Treat CLI and Why OBLs Are Needed
10/18/2023
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret...
10/18/2023
Vascular Disease Management
Drs Wiechmann and Saab
Vascular Voices Podcast
How the Outpatient Endovascular and Interventional Society Can Help Improve Office-Based Labs
07/25/2023
Bret N. Wiechmann, MD, FSIR, FAHA; Fadi Saab, MD, FACC, FSCAI
In this episode, Dr Bret Wiechmann, interventional radiologist and president of the OEIS joins Dr Fadi Saab, interventional cardiologist, to talk about the OEIS and the important role it plays in improving outpatient practice.
In this episode, Dr Bret Wiechmann, interventional radiologist and president of the OEIS joins Dr Fadi Saab, interventional cardiologist, to talk about the OEIS and the important role it plays in improving outpatient practice.
In this episode, Dr Bret...
07/25/2023
Vascular Disease Management
Video
Improving Outpatient Practice With the Outpatient Endovascular and Interventional Society (OEIS)
02/22/2023
Dr. Bret Wiechmann and Dr. Fadi Saab talk about the Outpatient Endovascular and Interventional Society (OEIS) and the important role it plays in improving outpatient practice.
Dr. Bret Wiechmann and Dr. Fadi Saab talk about the Outpatient Endovascular and Interventional Society (OEIS) and the important role it plays in improving outpatient practice.
Dr. Bret Wiechmann and Dr. Fadi...
02/22/2023
Vascular Disease Management
Drs Rundback and Wiechmann
Vascular Voices Podcast
Outpatient Practice and the Treatment of Advanced Vascular Disease and Critical Limb Ischemia
01/25/2023
Bret N. Wiechmann, MD, FSIR, FAHA; John H. Rundback, MD, FAHA, FSIR
A discussion with Dr. Bret Wiechmann and Dr. John Rundback.
A discussion with Dr. Bret Wiechmann and Dr. John Rundback.
A discussion with Dr. Bret...
01/25/2023
Vascular Disease Management
Video
Outpatient Practice and the Treatment of Advanced Vascular Disease and Critical Limb Ischemia
09/14/2022
Bret N. Wiechmann, MD, FSIR, FAHA; John H. Rundback, MD, FAHA, FSIR
Drs. Wiechmann and Rundback discuss the role of OBLs in treating advanced vascular disease and CLI, and talk about how OEIS serves the outpatient endovascular community.
Drs. Wiechmann and Rundback discuss the role of OBLs in treating advanced vascular disease and CLI, and talk about how OEIS serves the outpatient endovascular community.
Drs. Wiechmann and Rundback...
09/14/2022
Vascular Disease Management
Video
Paul Gagne, MD, Reflects on How the OBL Space Is Expanding
02/16/2022
Paul Gagne, MD, FACS, RVT
Dr. Paul Gagne discusses what's new in the expanding world of OBLs.
Dr. Paul Gagne discusses what's new in the expanding world of OBLs.
Dr. Paul Gagne discusses what's...
02/16/2022
Vascular Disease Management
Dr Setayesh Sotoudehnia
Interview
Making the Impossible Possible: MR-Guided Interventional Oncology
03/27/2025
Setayesh Sotoudehnia, MD
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh...
03/27/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Dr Dania Daye
ISET 2025
AI Governance in Procedural Practices: Who and How to Decide What Algorithms to Implement
03/24/2025
Dania Daye, MD, PhD
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses...
03/24/2025
Vascular Disease Management
Dr William Gray
ISET 2025
The Next Generation of Radiation Protection Solutions: The Dynamic SMART Shield
03/21/2025
William A. Gray, MD, FACC, FSCAI; Ripal T. Gandhi, MD, FSIR, FSVM
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD,...
03/21/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Sanjay Misra
ISET 2025
Present and Future Applications of AI in Vascular Therapy
03/20/2025
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional...
03/20/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

News
American College of Surgeons and the Society for Vascular Surgery Release Standards for Outpatient Vascular Care
09/19/2023
CHICAGO (Sept. 19, 2023): The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has released new standards for outpatient vascular centers to help them provide optimal care and treatment of patients receiving...
CHICAGO (Sept. 19, 2023): The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has released new standards for outpatient vascular centers to help them provide optimal care and treatment of patients receiving...
CHICAGO (Sept. 19, 2023): The...
09/19/2023
Vascular Disease Management
News
Philips and BIOTRONIK Expand Care for Out-of-Hospital Cardiology Labs With New Strategic Alliance
06/27/2023

Philips Press Release

Philips Press Release
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of...
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of...
Alliance further strengthens...
06/27/2023
Vascular Disease Management
News
Dialysis Vascular Access Coalition (DVAC) Supports New Legislation to Stop Ongoing Cuts to Office-Based Specialists
06/15/2023
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the...
06/15/2023
Cath Lab Digest
News
HST Pathways Announces Merger with Clariti Health for Enhanced Patient Price Transparency Resources as Part of its End-to-End Premium Technology Solution
06/01/2021
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST...
06/01/2021
Vascular Disease Management
News
Cardiovascular Institute of the South (CIS) Completes First Procedure in New Ambulatory Surgery Center
01/05/2021
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the...
01/05/2021
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use